Amalgamated Bank boosted its holdings in shares of Humana Inc (NYSE:HUM) by 2.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,339 shares of the insurance provider’s stock after acquiring an additional 426 shares during the period. Amalgamated Bank’s holdings in Humana were worth $4,224,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also modified their holdings of the business. Twin Capital Management Inc. boosted its holdings in shares of Humana by 14.6% in the 3rd quarter. Twin Capital Management Inc. now owns 14,914 shares of the insurance provider’s stock valued at $3,634,000 after buying an additional 1,895 shares in the last quarter. Cadence Capital Management LLC boosted its holdings in shares of Humana by 3.6% in the 3rd quarter. Cadence Capital Management LLC now owns 5,887 shares of the insurance provider’s stock valued at $1,434,000 after buying an additional 205 shares in the last quarter. Schroder Investment Management Group boosted its holdings in shares of Humana by 62.9% in the 3rd quarter. Schroder Investment Management Group now owns 95,777 shares of the insurance provider’s stock valued at $23,250,000 after buying an additional 36,985 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its holdings in shares of Humana by 9.6% in the 3rd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 11,753 shares of the insurance provider’s stock valued at $2,863,000 after buying an additional 1,031 shares in the last quarter. Finally, Trexquant Investment LP bought a new stake in shares of Humana in the 3rd quarter valued at about $1,543,000. Institutional investors own 94.18% of the company’s stock.

Humana Inc (NYSE HUM) traded up $0.66 on Wednesday, reaching $244.22. 1,075,100 shares of the company’s stock were exchanged, compared to its average volume of 1,378,973. Humana Inc has a 12 month low of $186.25 and a 12 month high of $264.56. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.35. The stock has a market cap of $34,359.28, a price-to-earnings ratio of 20.52, a PEG ratio of 1.65 and a beta of 0.91.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, November 8th. The insurance provider reported $3.39 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.27 by $0.12. Humana had a net margin of 3.49% and a return on equity of 15.99%. The company had revenue of $13.28 billion during the quarter, compared to analyst estimates of $13.41 billion. During the same period last year, the firm posted $3.18 EPS. Humana’s revenue for the quarter was down 3.0% compared to the same quarter last year. equities research analysts anticipate that Humana Inc will post 11.63 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, December 29th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 0.66%. The ex-dividend date of this dividend is Thursday, December 28th. Humana’s dividend payout ratio is presently 12.59%.

HUM has been the subject of a number of recent analyst reports. ValuEngine upgraded shares of Humana from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. Credit Suisse Group initiated coverage on shares of Humana in a research note on Thursday, November 2nd. They issued a “neutral” rating and a $256.00 target price for the company. BidaskClub upgraded shares of Humana from a “sell” rating to a “hold” rating in a research note on Thursday, August 10th. UBS reiterated a “neutral” rating and issued a $250.00 target price (up from $237.00) on shares of Humana in a research note on Wednesday, August 9th. Finally, Cantor Fitzgerald reiterated a “neutral” rating and issued a $223.00 target price (up from $200.00) on shares of Humana in a research note on Thursday, August 3rd. Thirteen research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. Humana has a consensus rating of “Hold” and a consensus price target of $252.81.

In other news, VP Timothy S. Huval sold 7,803 shares of Humana stock in a transaction that occurred on Friday, September 1st. The shares were sold at an average price of $258.14, for a total transaction of $2,014,266.42. Following the completion of the transaction, the vice president now directly owns 8,831 shares of the company’s stock, valued at approximately $2,279,634.34. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Elizabeth D. Bierbower sold 9,786 shares of Humana stock in a transaction that occurred on Friday, September 1st. The shares were sold at an average price of $259.00, for a total transaction of $2,534,574.00. Following the transaction, the insider now directly owns 18,042 shares of the company’s stock, valued at $4,672,878. The disclosure for this sale can be found here. 0.80% of the stock is owned by insiders.

TRADEMARK VIOLATION WARNING: “Amalgamated Bank Acquires 426 Shares of Humana Inc (HUM)” was originally posted by Daily Political and is the property of of Daily Political. If you are viewing this article on another site, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this article can be viewed at https://www.dailypolitical.com/2017/11/29/amalgamated-bank-acquires-426-shares-of-humana-inc-hum.html.

Humana Company Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc and related companies with MarketBeat.com's FREE daily email newsletter.